Blueprint Medicines Corp - BPMC - stock price prediction, stock price target, analyst ratings from 19 analysts

Blueprint Medicines Corp has a share price target of US$ 131, revenue growth forecast of 41.6%, and profit growth estimate of 34.9% for FY25, based on top 19 analyst calls.